Literature DB >> 6401332

Increased synthesis of thromboxane A2 by platelets from patients with Kawasaki disease.

T Hidaka, M Nakano, T Ueta, Y Komatsu, M Yamamoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6401332     DOI： 10.1016/s0022-3476(83)80300-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  6 in total

1.  Abnormalities of vascular prostaglandins in Henoch-Schönlein purpura.

Authors:  S Turi; J J Belch; T J Beattie; C D Forbes
Journal:  Arch Dis Child       Date:  1986-02       Impact factor: 3.791

2.  Long-term anticoagulation in Kawasaki disease: Initial use of low molecular weight heparin is a viable option for patients with severe coronary artery abnormalities.

Authors:  Cedric Manlhiot; Leonardo R Brandão; Zeeshanefatema Somji; Amy L Chesney; Catherine MacDonald; Rebecca C Gurofsky; Tarun Sabharwal; Nita Chahal; Brian W McCrindle
Journal:  Pediatr Cardiol       Date:  2010-04-30       Impact factor: 1.655

3.  Kawasaki syndrome.

Authors:  J Price
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-28

4.  Plasma factors influencing PGI2-like activity in patients with IgA nephropathy and Henoch-Schönlein purpura.

Authors:  S Túri; J Nagy; I Haszon; Z Havass; M Németh; C Bereczki
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

5.  Increased generation of cysteinyl leukotrienes in Kawasaki disease.

Authors:  E Mayatepek; W D Lehmann
Journal:  Arch Dis Child       Date:  1995-06       Impact factor: 3.791

6.  Salicylate treatment in Kawasaki disease: high dose or low dose?

Authors:  T Akagi; H Kato; O Inoue; N Sato
Journal:  Eur J Pediatr       Date:  1991-07       Impact factor: 3.183
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.